A Phase II Clinical Study of mFOLFOX6 Plus Bevacizumab as First-line Therapy for Japanese Advanced/Recurrent Colorectal Cancer Patients

OBJECTIVE: In Japan, there had been no prospective clinical studies conducted in terms of modified FOLFOX6 + bevacizumab therapy. We performed a post-marketing Phase II multicenter clinical study to examine the efficacy and safety of this regimen as first-line therapy for Japanese patients with adva...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishina, Tomohiro, Takano, Yoshinao, Denda, Tadamichi, Yasui, Hisateru, Takeda, Koji, Ura, Takashi, Esaki, Taito, Okuyama, Yusuke, Kondo, Ken, Takahashi, Yasuo, Sugiyama, Yasuyuki, Muro, Kei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2013
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3814899/
https://www.ncbi.nlm.nih.gov/pubmed/23999770
http://dx.doi.org/10.1093/jjco/hyt127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3814899/
https://www.ncbi.nlm.nih.gov/pubmed/23999770
http://dx.doi.org/10.1093/jjco/hyt127

Ejemplares similares